Jeffrey M. Dayno - 26 May 2023 Form 4/A - Amendment Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
PRESIDENT, CEO, Director
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol
HRMY
Transactions as of
26 May 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
31 May 2023, 16:37:09 UTC
Date Of Original Report
30 May 2023
Previous filing
04 Nov 2022
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +125,000 $0.000000 125,000 26 May 2023 Common Stock 125,000 $35.56 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the exercise price of the granted options previously reported as being $35.99 to $35.56.
F2 The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025.